1. Home
  2. LASR vs LGND Comparison

LASR vs LGND Comparison

Compare LASR & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

N/A

Current Price

$66.59

Market Cap

4.1B

Sector

Technology

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$293.98

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
LGND
Founded
2000
1987
Country
United States
United States
Employees
N/A
68
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
LASR
LGND
Price
$66.59
$293.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
7
Target Price
$54.31
$256.29
AVG Volume (30 Days)
1.1M
297.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
62.99
N/A
EPS
0.01
N/A
Revenue
$191,359,000.00
N/A
Revenue This Year
$10.91
$1.25
Revenue Next Year
$14.32
$19.41
P/E Ratio
$7,002.00
$76.27
Revenue Growth
38.09
N/A
52 Week Low
$19.33
$131.67
52 Week High
$86.95
$326.63

Technical Indicators

Market Signals
Indicator
LASR
LGND
Relative Strength Index (RSI) 45.87 53.53
Support Level $64.13 $290.20
Resistance Level $72.47 $326.63
Average True Range (ATR) 6.26 10.65
MACD 0.17 -3.64
Stochastic Oscillator 41.85 23.41

Price Performance

Historical Comparison
LASR
LGND

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: